(Q28204367)

ORCID Public Data File 2021

author name string

David J Brunswick

1

0 references

Jay D Amsterdam

2

0 references

Jan Fawcett

3

0 references

Frederick W Reimherr

5

0 references

Jerrold F Rosenbaum

6

0 references

Charles M Beasley

Journal of Affective Disorders

7

0 references

language of work or name

English

0 references

publication date

April 2002

0 references

published in

0 references

volume

68

0 references

issue

2-3

0 references

page(s)

243-9

0 references

cites work

The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Sertraline in the prevention of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Serum fluoxetine and norfluoxetine concentrations and antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Imipramine and amitriptyline plasma concentrations and clinical response in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Early nonresponse to fluoxetine as a predictor of poor 8-week outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021

The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900333-5

7 January 2021